	Structurally Modified Cyclodextrins in Topical Nanotechnology: Advancing Barrier-Penetrating Drug Delivery Strategies for Psoriasis Management. AAPS PharmSciTech Khude H, Shende P. PMID: 41578094 [PubMed - indexed for MEDLINE]
	Infection risk among psoriasis biologic-new users: a cohort study on the French National Health Data System. J Am Acad Dermatol Khoi Le TT, Vo TT, Sbidian E. PMID: 41577189 [PubMed - as supplied by publisher]
	Achieving durable psoriasis remission with nucleic acid therapeutics. Drug Discov Today Zhou H, Lu J, Yin B, Zhu Q, Chen Z. PMID: 41577170 [PubMed - as supplied by publisher]
	The role of nitric oxide in skin inflammation and the pathogenesis of psoriasis. Biochem Pharmacol Staniszewska M, Kie, Bakinowska E, Plewa P, S, Pawlik A. PMID: 41577049 [PubMed - as supplied by publisher]
	Clinical proof of concept for small molecule mediated inhibition of IL-17 in psoriasis. PLoS One Warren RB, Hunter HJA, Papp KA, Gordon KB, Tang MT, Enejosa JV, Huang KC, Raha D, Batugedara HM, Skinner C, Kobel PA, Rademacher PM, Ghilardi N, Fatheree P, Jacobsen JR, Lu TT. PMID: 41575986 [PubMed - indexed for MEDLINE]
	Guselkumab Improves Patient-Reported Outcomes Among Participants with Psoriatic Arthritis and Inadequate Response to Tumor Necrosis Factor Inhibitors in the COSMOS Study. Rheumatol Ther Gossec L, Baraliakos X, Galloway J, Oke V, Sfikakis P, Rampakakis E, Sharaf M, Lavie F, McInnes IB. PMID: 41575731 [PubMed - as supplied by publisher]
	Real-World Effectiveness and Safety of Tildrakizumab for Plaque Psoriasis: A 3-Year International Multicenter Retrospective Study. Dermatol Ther (Heidelb) Torres T, Sood S, Yilmaz O, Vender RB, Prajapati VH, Puig L, Megna M, Marzano AV, Gisondi P, Carrascosa JM, Dauden E, Llamas-Velasco M, Balato A, Leal BG, Prignano F, Bellinato F, Silvi G, Di Brizzi EV, Potestio L, Carrera CG, López-Ferrer A, Del-Alcazar E, Mufti A, Maul LV, Piaserico S, Maul JT, Yeung J. PMID: 41575604 [PubMed - as supplied by publisher]
	Single-Cell RNA Sequencing Revealing Dysregulated Perturbations of Tregs in Psoriasis and Construction of a Treg-Related Diagnostic Model via a 101- Combination Machine Learning Computational Framework. Endocr Metab Immune Disord Drug Targets Huang Z, Sui Y, Liu S. PMID: 41572692 [PubMed - as supplied by publisher]
	Evaluating Psoriasis Severity Using the Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio: A Systematic Review and Meta-Analysis. Exp Dermatol Shen YH, Ho PY, Huang YC. PMID: 41572666 [PubMed - indexed for MEDLINE]
	Risankizumab super responders in moderate-to-severe psoriasis: prevalence, predictors, and long-term maintenance in a multicenter, international, real-world cohort. J Dermatolog Treat Orsini D, Potestio L, Megna M, Assorgi C, Costanzo A, Dattola A, Fargnoli MC, Ferreira P, Ferreirinha A, Gaiani FM, Graceffa D, Ibba L, João AL, Leal B, Leite L, Paiva Lopes MJ, Luz M, Malagoli P, Mendes-Bastos P, Messina F, Narcisi A, Pellacani G, Pimenta R, Roda Â, Tommasino N, Valério J, Torres T. PMID: 41572535 [PubMed - indexed for MEDLINE]
	Incidence rate and risk factors of arrhythmias in patients with psoriatic arthritis. RMD Open Almansouri AY, Li J, Bumbulis L, Alhadari A, Colaco K, Harvey P, Akhtari S, Chandran V, Gladman DD, Cook RJ, Eder L. PMID: 41571321 [PubMed - indexed for MEDLINE]
	Immunoprotective and neuroprotective properties of gut microbiome in psoriasis. J Transl Autoimmun Yahyapour A, Najafi A, Ahmadi A, Salarizadeh N. PMID: 41568321 [PubMed]
	Efficacy and safety of vunakizumab in moderate-to-severe plaque psoriasis patients with different body mass index: a post hoc analysis based on a phase III trial. Front Pharmacol Wang X, Li L. PMID: 41567644 [PubMed]
	Mechanistic insights into psoriasis and type 2 diabetes mellitus comorbidity - Implications for treatment: A review. Biomol Biomed Ouyang L, Li Z, Zeng Y. PMID: 41564383 [PubMed - as supplied by publisher]
	Neutrophil-Galectin-9 Axis Linking Innate and Adaptive Immunity in ATL, SÃ©zary Syndrome, COVID-19, and Psoriasis: An AI-Assisted Integrative Review. Reports (MDPI) Hattori T. PMID: 41562814 [PubMed]
	Association between out-of-pocket costs and treatment patterns in psoriasis and psoriatic arthritis: A claims-based cohort study. JAAD Int Roberts AM, Jeong C, Chou P, Ma EJ, Katz A, Yan MJ, Johnsen N, Nong Y, Armstrong AW. PMID: 41561196 [PubMed]
	Patterns of spinal new bone formation in patients with axial spondyloarthritis, psoriatic arthritis, rheumatoid arthritis and healthy controls: a low-dose CT study. RMD Open Willesen ST, Møller JM, Gosvig KK, Pedersen SJ, Hadsbjerg AEF, Georgiadis S, Østergaard M. PMID: 41558804 [PubMed - indexed for MEDLINE]
	Icotrokinra: A Promising Oral IL-23 Receptor Inhibitor for Moderate-to-Severe Plaque Psoriasis. Skin Therapy Lett Okundia F, Shakhashiro M, Tyring SK. PMID: 41557953 [PubMed - indexed for MEDLINE]
	A review of current therapeutics for psoriasis: Systemic and topical use of non-biological drugs. Eur J Clin Pharmacol Gün E, Sevgi S, Demirçi B, Ar, Helvac, Büyükta, Sezen SF. PMID: 41553544 [PubMed - indexed for MEDLINE]
	Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a BTLA Agonist Antibody (Venanprubart) in Healthy Participants, Patients with Systemic Lupus Erythematosus, and Patients with Psoriasis: Results From Three Phase 1 Studies. Clin Pharmacol Drug Dev Vendel AC, Benichou O, Chang CY, Datta G, Ferrante A, Ghosh I, Moser BA, Sweeney SE, Witcher J, Linnik MD. PMID: 41549797 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 27330

Page 1 of 1367



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy